Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: silodosin

« Back to Dashboard

Summary for Generic Name: silodosin

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list5
Suppliers: see list2
Formulation / Manufacturing:see details

Pharmacology for Ingredient: silodosin

Clinical Trials for: silodosin

Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Status: Completed Condition: Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Status: Completed Condition: Benign Prostatic Hyperplasia

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH
Status: Completed Condition: Benign Prostatic Hypertrophy

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
Status: Completed Condition: Benign Prostatic Hyperplasia

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Status: Recruiting Condition: Nocturia; Benign Prostatic Hyperplasia

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Status: Completed Condition: Nocturia; Prostatic Hyperplasia

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
Status: Completed Condition: Neurogenic Bladder; Voiding Dysfunction

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Status: Not yet recruiting Condition: Urinary Problems; Prostate Cancer

Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
Status: Completed Condition: Benign Prostatic Hyperplasia

A Dose-finding Study of Silodosin in Patients With Urinary Calculi
Status: Completed Condition: Urinary Calculus

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
RAPAFLO
silodosin
CAPSULE;ORAL022206Oct 8, 2008RXYes<disabled><disabled>
Watson Labs
RAPAFLO
silodosin
CAPSULE;ORAL022206Oct 8, 2008RXYes5,387,603<disabled>YY<disabled>
Watson Labs
RAPAFLO
silodosin
CAPSULE;ORAL022206Oct 8, 2008RXNo<disabled><disabled>
Watson Labs
RAPAFLO
silodosin
CAPSULE;ORAL022206Oct 8, 2008RXNo5,387,603<disabled>YY<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc